PharmiWeb.com - Global Pharma News & Resources
25-Jan-2019

Global Gouty Arthritis (Gout) Pipeline Insight Report 2019 - ResearchAndMarkets.com

The "Gouty Arthritis (Gout) - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

"Gouty Arthritis (Gout) - Pipeline Insight, 2019 report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Gouty Arthritis (Gout) development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:

  • Clinical
  • Non-clinical
  • Inactive: Discontinued and/or Dormant

Descriptive coverage of pipeline development activities for Gouty Arthritis (Gout)

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Pipeline Therapeutics assessment of products for Gouty Arthritis (Gout)

The report assesses the active Gouty Arthritis (Gout) pipeline products by developmental stage, product type, molecule type, and administration route.

Scope of the report

  • The report provides a snapshot of the pipeline development for the Gouty Arthritis (Gout)
  • The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Gouty Arthritis (Gout)
  • The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Gouty Arthritis (Gout)
  • The report also covers the dormant and discontinued pipeline projects related to the Gouty Arthritis (Gout)

Companies Mentioned

  • Allena Pharmaceuticals
  • AstraZeneca Plc
  • C&C Research Laboratories
  • Cell Medica Ltd
  • CymaBay Therapeutics Inc
  • Genentech Inc
  • Response BioPharma Inc
  • Jiangsu Hengrui Medicine Co Ltd
  • Monosol Rx LLC
  • Opsona Therapeutics Ltd
  • Polaris Pharmaceuticals Inc

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/r32gv8/global_gouty?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190125005421/en/

Editor Details

Last Updated: 25-Jan-2019